DA, Elizabeth Jungman, J.D., M.P.H. Chief of Staff of the FDA | Official Website
DA, Elizabeth Jungman, J.D., M.P.H. Chief of Staff of the FDA | Official Website
This is a 100% increase over the number of companies cited in the previous year.
Of the 58 citations issued, the most common citations include:
- You did not establish written procedures for calibrating instruments and controls that you use in manufacturing or testing a component or dietary supplement.
- You did not establish an identity specification for each component.
- You did not establish component specifications for purity, strength and composition.
Most of the companies cited were involved in the Food and Cosmetics sector.
Of the companies cited, two should take voluntary actions to correct their managing operations. Additionally, one company had to take regulatory and/or administrative actions (50%).
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Issue Cited |
---|---|---|---|
Afton Scientific, LLC | Food and Cosmetics | 10/06/2023 | Sanitation preventive controls - Appropriate (Adequate) |
Afton Scientific, LLC | Food and Cosmetics | 10/06/2023 | Supply-chain program - Assurance (Adequate) |
Afton Scientific, LLC | Food and Cosmetics | 10/06/2023 | Procedures not in writing, fully followed |
Afton Scientific, LLC | Food and Cosmetics | 10/06/2023 | Training , Education , Experience overall |
Afton Scientific, LLC | Food and Cosmetics | 10/06/2023 | Absence of Written Procedures |
Afton Scientific, LLC | Food and Cosmetics | 10/06/2023 | Control procedures to monitor and validate performance |
Afton Scientific, LLC | Food and Cosmetics | 10/06/2023 | Storage under appropriate conditions |
Afton Scientific, LLC | Food and Cosmetics | 10/06/2023 | Drug products - samples representative, identified properly |
Afton Scientific, LLC | Biologics | 10/06/2023 | Sanitation preventive controls - Appropriate (Adequate) |
Afton Scientific, LLC | Biologics | 10/06/2023 | Supply-chain program - Assurance (Adequate) |
Afton Scientific, LLC | Biologics | 10/06/2023 | Procedures not in writing, fully followed |
Afton Scientific, LLC | Biologics | 10/06/2023 | Training , Education , Experience overall |
Afton Scientific, LLC | Biologics | 10/06/2023 | Absence of Written Procedures |
Afton Scientific, LLC | Biologics | 10/06/2023 | Control procedures to monitor and validate performance |
Afton Scientific, LLC | Biologics | 10/06/2023 | Storage under appropriate conditions |
Afton Scientific, LLC | Biologics | 10/06/2023 | Drug products - samples representative, identified properly |
Biomic Sciences, LLC | Drugs | 08/31/2023 | Procedures - calibrating instruments |
Biomic Sciences, LLC | Drugs | 08/31/2023 | Specifications - component identity |
Biomic Sciences, LLC | Drugs | 08/31/2023 | Specifications-component purity, strength, composition |
Biomic Sciences, LLC | Drugs | 08/31/2023 | Specifications - contamination limits |
Biomic Sciences, LLC | Drugs | 08/31/2023 | Specifications - identity, purity, strength, composition |
Biomic Sciences, LLC | Drugs | 08/31/2023 | Specifications met - verify; finished batch |
Biomic Sciences, LLC | Drugs | 08/31/2023 | Components - quarantine |
Biomic Sciences, LLC | Drugs | 08/31/2023 | Master manufacturing record - each batch |
Biomic Sciences, LLC | Drugs | 08/31/2023 | Batch record - complete |
Biomic Sciences, LLC | Drugs | 08/31/2023 | Scheduled processes not established |
Biomic Sciences, LLC | Drugs | 08/31/2023 | Procedures for non-sterile drug products |
Biomic Sciences, LLC | Drugs | 08/31/2023 | Microbiological testing |
Biomic Sciences, LLC | Drugs | 08/31/2023 | Quality control - processes, specifications, written procedures |
Biomic Sciences, LLC | Drugs | 08/31/2023 | Quality control operations - master manufacturing record, modifications |
Biomic Sciences, LLC | Food and Cosmetics | 08/31/2023 | Procedures - calibrating instruments |
Biomic Sciences, LLC | Food and Cosmetics | 08/31/2023 | Specifications - component identity |
Biomic Sciences, LLC | Food and Cosmetics | 08/31/2023 | Specifications-component purity, strength, composition |
Biomic Sciences, LLC | Food and Cosmetics | 08/31/2023 | Specifications - contamination limits |
Biomic Sciences, LLC | Food and Cosmetics | 08/31/2023 | Specifications - identity, purity, strength, composition |
Biomic Sciences, LLC | Food and Cosmetics | 08/31/2023 | Specifications met - verify; finished batch |
Biomic Sciences, LLC | Food and Cosmetics | 08/31/2023 | Components - quarantine |
Biomic Sciences, LLC | Food and Cosmetics | 08/31/2023 | Master manufacturing record - each batch |
Biomic Sciences, LLC | Food and Cosmetics | 08/31/2023 | Batch record - complete |
Biomic Sciences, LLC | Food and Cosmetics | 08/31/2023 | Scheduled processes not established |
Biomic Sciences, LLC | Food and Cosmetics | 08/31/2023 | Procedures for non-sterile drug products |
Biomic Sciences, LLC | Food and Cosmetics | 08/31/2023 | Microbiological testing |
Biomic Sciences, LLC | Food and Cosmetics | 08/31/2023 | Quality control - processes, specifications, written procedures |
Biomic Sciences, LLC | Food and Cosmetics | 08/31/2023 | Quality control operations - master manufacturing record, modifications |
Biomic Sciences, LLC | Veterinary | 08/31/2023 | Procedures - calibrating instruments |
Biomic Sciences, LLC | Veterinary | 08/31/2023 | Specifications - component identity |
Biomic Sciences, LLC | Veterinary | 08/31/2023 | Specifications-component purity, strength, composition |
Biomic Sciences, LLC | Veterinary | 08/31/2023 | Specifications - contamination limits |
Biomic Sciences, LLC | Veterinary | 08/31/2023 | Specifications - identity, purity, strength, composition |
Biomic Sciences, LLC | Veterinary | 08/31/2023 | Specifications met - verify; finished batch |
Biomic Sciences, LLC | Veterinary | 08/31/2023 | Components - quarantine |
Biomic Sciences, LLC | Veterinary | 08/31/2023 | Master manufacturing record - each batch |
Biomic Sciences, LLC | Veterinary | 08/31/2023 | Batch record - complete |
Biomic Sciences, LLC | Veterinary | 08/31/2023 | Scheduled processes not established |
Biomic Sciences, LLC | Veterinary | 08/31/2023 | Procedures for non-sterile drug products |
Biomic Sciences, LLC | Veterinary | 08/31/2023 | Microbiological testing |
Biomic Sciences, LLC | Veterinary | 08/31/2023 | Quality control - processes, specifications, written procedures |
Biomic Sciences, LLC | Veterinary | 08/31/2023 | Quality control operations - master manufacturing record, modifications |